EBITDA Growth
-14.92%
TTM · Period ending:
CBT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-14.92%period ending
Latest reported-14.92%period ending
CBT TTM EBITDA YoY % (2.77% → -14.92%)
Year-over-year change
High-resolution chart · PNG
CBT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -6.6339% | |
| -4.484% | |
| -7.3961% | |
| 9.6197% | |
| -0.3977% | |
| 2.005% | |
| -0.698% | |
| -4.8358% | |
| 0.1532% | |
| -3.7394% | |
| 5.3726% | |
| 11.0061% | |
| 11.7426% | |
| 8.4369% | |
| -4.6646% | |
| -17.0308% | |
| -21.7729% | |
| -20.7567% | |
| -15.0699% | |
| -4.0065% | |
| 6.9608% | |
| 22.5079% | |
| 34.4708% | |
| 42.545% | |
| 36.7947% | |
| 26% | |
| 19.567% | |
| 10.3171% | |
| 10.9565% | |
| 9.9868% | |
| 0% | |
| -2.4742% | |
| 2.1314% | |
| 12.1915% | |
| 22.551% | |
| 15.5312% | |
| -9.0468% | |
| -24.5999% | |
| -25.0191% | |
| -14.9858% | |
| 120.9104% | |
| 134.6799% | |
| 188.6703% | |
| 93.7991% | |
| -479.6409% | |
| -392.1569% | |
| -254.9947% | |
| 31.6116% | |
| -30.9803% | |
| -23.6835% | |
| -10.6203% | |
| -23.7195% | |
| 319.9814% | |
| 253.5097% | |
| 98.5075% | |
| -22.0516% | |
| 2.7698% |